Melanóma: vizsgálatok itt: Szingapúr

3 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.

• 1/2. fázisTaking people
  Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

  Where

  Singapore

  Életkor

  18 év and over

  People

  340 worldwide

  Run by

  Inhibrx Biosciences, Inc

  See details and how to joinNCT04198766
• 3. fázisTaking people
  Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.

  Where

  Singapore

  Életkor

  18 év to 70 év

  People

  670 worldwide

  Run by

  Iovance Biotherapeutics, Inc.

  See details and how to joinNCT05727904 · EU 2022-503140-41-00
• No phaseTaking people
  Using QPOP to Predict Treatment for Sarcomas and Melanomas

  Where

  Singapore

  Életkor

  21 év to 99 év

  People

  100

  Run by

  National Cancer Centre, Singapore

  See details and how to joinNCT04986748